October 8, 2019 / 1:28 AM / 15 days ago

IN BRIEF: High court rebuffs Pfizer’s bid to move Calif. Lipitor cases to fed court

Lawsuits by thousands of women who claim they developed diabetes as a result of taking the anti-cholesterol drug Lipitor will remain in California state court, as the U.S. Supreme Court denied a petition for certiorari in which Pfizer Inc argued that it should be allowed to transfer the cases to federal court.

Pfizer, which has denied the women’s allegations, argued that a state court judge triggered the Class Action Fairness Act’s 100-plaintiff threshold for federal jurisdiction over mass actions by deciding, sua sponte, to consolidate actions involving about 4,800 women. To read the full story on Westlaw Practitioner Insights, click here: bit.ly/31Unv29

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below